申请人:Aventis Pharmaceuticals, Inc.
公开号:US06329392B1
公开(公告)日:2001-12-11
The present invention relates to novel substituted piperidine derivatives of the formula
stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic diseases including: seasonal rhinitis, allergic rhinitis, and sinusitis.
本发明涉及一种新型的取代哌啶衍生物,其化学式为其立体异构体和药学上可接受的盐,可用作组胺受体拮抗剂和速激肽受体拮抗剂。这类拮抗剂在治疗过敏性疾病中很有用,包括:季节性鼻炎、过敏性鼻炎和鼻窦炎。